- Home
- EDRY vs SER Comparison
EDRY vs SER Comparison
Compare EDRY & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- SER
- Stock Information
- Founded
- EDRY 2018
- SER 2017
- Country
- EDRY Greece
- SER United States
- Employees
- EDRY N/A
- SER 13
- Industry
- EDRY Marine Transportation
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- EDRY Consumer Discretionary
- SER Health Care
- Exchange
- EDRY Nasdaq
- SER Nasdaq
- Market Cap
- EDRY 35.4M
- SER 41.2M
- IPO Year
- EDRY N/A
- SER 2018
- Fundamental
- Price
- EDRY $12.53
- SER $3.96
- Analyst Decision
- EDRY
- SER Strong Buy
- Analyst Count
- EDRY 0
- SER 2
- Target Price
- EDRY N/A
- SER $13.00
- AVG Volume (30 Days)
- EDRY 3.0K
- SER 29.6K
- Earning Date
- EDRY 11-10-2025
- SER 11-11-2025
- Dividend Yield
- EDRY N/A
- SER N/A
- EPS Growth
- EDRY N/A
- SER N/A
- EPS
- EDRY N/A
- SER N/A
- Revenue
- EDRY $49,707,775.00
- SER $130,000.00
- Revenue This Year
- EDRY N/A
- SER $134.46
- Revenue Next Year
- EDRY $20.65
- SER N/A
- P/E Ratio
- EDRY N/A
- SER N/A
- Revenue Growth
- EDRY N/A
- SER N/A
- 52 Week Low
- EDRY $7.60
- SER $3.70
- 52 Week High
- EDRY $16.20
- SER $7.92
- Technical
- Relative Strength Index (RSI)
- EDRY 60.29
- SER 29.95
- Support Level
- EDRY $12.09
- SER $4.60
- Resistance Level
- EDRY $13.00
- SER $5.00
- Average True Range (ATR)
- EDRY 0.27
- SER 0.29
- MACD
- EDRY 0.04
- SER -0.11
- Stochastic Oscillator
- EDRY 100.00
- SER 16.40
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.